Prognostic impact of hs‐CRP and IL‐6 in patients with persistent atrial fibrillation treated with electrical cardioversion

References

• Feinberg W. M., Blackshear J. L., Laupacis A., Kronmal R., Hart R. G. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995; 155: 469–73
   PubMed Web of Science ®Google Scholar
• Friberg J., Scharling H., Gadsboll N., Jensen G. B. Sex‐specific increase in the prevalence of atrial fibrillation (the Copenhagen city heart study). Am J Cardiol 2003; 92: 1419–23
   PubMed Web of Science ®Google Scholar
• Fuster V., Rydén L. E., Asinger R. W., Cannom D. S., Crijns H. J., Frye R. L., Halperin J. L., Kay G. N., Klein W. W., Lévy S., McNamara R. L., Prystowsky E. N., Wann L. S., Wyse D. G., Gibbons R. J., Antman E. M., Alpert J. S., Faxon D. P., Fuster V., Gregoratos G., Hiratzka L. F., Jacobs A. K., Russell R. O., Smith S. C., Jr, Klein W. W., Alonso‐Garcia A., Blomström‐Lundqvist C., de Backer G., Flather M., Hradec J., Oto A., Parkhomenko A., Silber S., Torbicki A. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European Society of Cardiology committee for practice guidelines and policy conferences (committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 2001; 38: 1231–65
   PubMed Web of Science ®Google Scholar
• Dahlin J., Svendsen P., Gadsboll N. Poor maintenance of sinus rhythm after electrical cardioversion of patients with atrial fibrillation or flutter: a five year follow‐up of 268 consecutive patients. Scand Cardiovasc J 2003; 37: 324–8
   PubMed Web of Science ®Google Scholar
• Chung M. K., Martin D. O., Sprecher D., Wazni O., Kanderian A., Carnes C. A., Bauer J. A., Tchou P. J., Niebauer M. J., Natale A., Van Wagoner D. R. C‐reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104: 2886–91
   PubMed Web of Science ®Google Scholar
• Engelmann M., Svendsen J. H. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 2005; 26: 2083–92
   PubMed Web of Science ®Google Scholar
• Watanabe E., Arakawa T., Uchiyama T., Kodama I., Hishida H. High‐sensitivity C‐reactive protein is predictive of successful electrical cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion. Int J Cardiol 2005; 108: 346–53
   PubMed Web of Science ®Google Scholar
• Kallergis E. M., Manios E. G., Kanoupakis E. M., Mavrakis H. E., Kolyvaki S. G., Lyrarakis G. M., Chlouverakis G. I., Vardas P. E. The role of the post‐cardioversion time course of hs‐CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation. Heart 2008; 94: 200–4
   PubMed Web of Science ®Google Scholar
• Loricchio M. L., Cianfrocca C., Pasceri V., Bianconi L., Auriti A., Calo L., Lamberti F., Castro A., Pandozi C., Palamara A., Santini M. Relation of C‐reactive protein to long‐term risk of recurrence of atrial fibrillation after electrical cardioversion. Am J Cardiol 2007; 99: 1421–4
   PubMed Web of Science ®Google Scholar
• Aviles R. J., Martin D. O., Apperson‐Hansen C., Houghtaling P. L., Rautaharju P., Kronmal R. A., Tracy R. P., Van Wagoner D. R., Psaty B. M., Lauer M. S., Chung M. K. Inflammation as a risk factor for atrial fibrillation. Circulation 2003; 108: 3006–10
   PubMed Web of Science ®Google Scholar
• Lo B., Fijnheer R., Nierich A. P., Bruins P., Kalkman C. J. C‐reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization. Ann Thorac Surg 2005; 79: 1530–5
   PubMed Web of Science ®Google Scholar
• Fujiki A., Sakamoto T., Nishida K., Mizumaki K., Inoue H. Relation of interleukin‐6 and C‐reactive protein levels to sinus maintenance after pharmacological cardioversion in persistent atrial fibrillation. J Cardiovasc Pharmacol 2007; 50: 264–6
   PubMed Web of Science ®Google Scholar
• Therkelsen S. K., Groenning B. A., Kjaer A., Svendsen J. H., Boje Jensen G. ANP and BNP in atrial fibrillation before and after cardioversion – and their relationship to cardiac volume and function. Int J Cardiol 2008; 127: 396–9
   PubMed Web of Science ®Google Scholar
• Lombardi F., Colombo A., Basilico B., Ravaglia R., Garbin M., Vergani D., Battezzati P. M., Fiorentini C. Heart rate variability and early recurrence of atrial fibrillation after electrical cardioversion. J Am Coll Cardiol 2001; 38: 1585–6
   PubMed Web of Science ®Google Scholar
• Wijfels M. C. E. F., Kirchhof C. J. H. J., Dorland R., Allessie M. A. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 1995; 92: 1954–68
   PubMed Web of Science ®Google Scholar
• Frustaci A., Chimenti C., Bellocci F., Morgante E., Russo M. A., Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96: 1180–4
   PubMed Web of Science ®Google Scholar
• Climent V., Marín F., Mainar L., Roldán V., García A., Martínez J. G., Lip G. Y. Influence of electrical cardioversion on inflammation and indexes of structural remodelling, in persistent atrial fibrillation. Int J Cardiol 2008, Epub ahead of print
   Web of Science ®Google Scholar
• Roldán V., Marín F., Blann A. D., García A., Marco P., Sogorb F., Lip G. Y. Interleukin‐6, endothelial activation and thrombogenesis in chronic atrial fibrillation. Eur Heart J 2003; 24: 1373–80
   PubMed Web of Science ®Google Scholar
• Chen M. C., Chang J. P., Liu W. H., Yang C. H., Chen Y. L., Tsai T. H., Wang Y. H., Pan K. L. Increased inflammatory cell infiltration in the atrial myocardium of patients with atrial fibrillation. Am J Cardiol 2008; 102: 861–5
   PubMed Web of Science ®Google Scholar
• Liuba I., Ahlmroth H., Jonasson L., Englund A., Jönsson A., Säfström K., Walfridsson H. Source of inflammatory markers in patients with atrial fibrillation. Europace 2008; 10: 848–53
   PubMed Web of Science ®Google Scholar
• Tveit A., Grundvold I., Olufsen M., Seljeflot I., Abdelnoor M., Arnesen H., Smith P. Candesartan in the prevention of relapsing atrial fibrillation. Int J Cardiol 2007; 120: 85–91
   PubMed Web of Science ®Google Scholar
• Dernellis J., Panaretou M. Relationship between C‐reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J 2004; 25: 1100–7
   PubMed Web of Science ®Google Scholar
• Holm T., Andreassen A. K., Ueland T., Kjekshus J., Frøland S. S., Kjekshus E., Simonsen S., Aukrust P., Gullestad L. Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients. Am J Cardiol 2001; 87: 815–18
   PubMed Web of Science ®Google Scholar
• Plenge J. K., Hernandez T. L., Weil K. M., Poirier P., Grunwald G. K., Marcovina S. M., Eckel R. H. Simvastatin lowers C‐reactive protein within 14 days: an effect independent of low‐density lipoprotein cholesterol reduction. Circulation 2002; 106: 1447–52
   PubMed Web of Science ®Google Scholar
• Ridker P. M., Rifai N., Pfeffer M. A., Sacks F., Braunwald E. Long‐term effects of pravastatin on plasma concentration of C‐reactive protein. Circulation 1999; 100: 230–5
   PubMed Web of Science ®Google Scholar
• Kastelein J. J., Akdim F., Stroes E. S., Zwinderman A. H., Bots M. L., Stalenhoef A. F., Visseren F. L., Sijbrands E. J., Trip M. D., Stein E. A., Gaudet D., Duivenvoorden R., Veltri E. P., Marais A. D., de Groot E., ENHANCE Investigators. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008; 358: 1431–43
   PubMed Web of Science ®Google Scholar
• Fauchier L., Pierre B., de Labriolle A., Grimard C., Zannad N., Babuty D. Antiarrhythmic effect of statin therapy and atrial fibrillation a meta‐analysis of randomized controlled trials. J Am Coll Cardiol 2008; 51: 828–35
   PubMed Web of Science ®Google Scholar
• Issac T. T., Dokainish H., Lakkis N. M. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol 2007; 50: 2021–8
   PubMed Web of Science ®Google Scholar